Takeda Pharms. U.S.A., Inc. v. Mylan Pharms., Inc.
Case Name: Takeda Pharms. U.S.A., Inc. v. Mylan Pharms., Inc., No. 19-2216-RGA, 2020 U.S. Dist. LEXIS 12753 (D. Del. Jan. 27, 2020) (Andrews, J.) Drug Product and Patent(s)-in-Suit: Colcrys®...
View ArticleGalderma Labs., L.P. v. Teva Pharms. USA, Inc.
Case Name: Galderma Labs., L.P. v. Teva Pharms. USA, Inc., No. 2019-2396 (Fed. Cir. Jan. 29, 2020) (Circuit Judges Moore, O’Malley, and Stoll presiding; Opinion by O’Malley, J.) (Appeal from D. Del.,...
View ArticleTakeda Pharms. Co. v. Torrent Pharms. Ltd.
Case Name: Takeda Pharms. Co. v. Torrent Pharms. Ltd., No. 17-3186 (SRC)(CLW)(cons.), 2020 U.S. Dist. LEXIS 18069 (D.N.J. Feb. 4, 2020) (Chesler, J.) Drug Product and Patent(s)-in-Suit: Nesina®...
View ArticlePiramal Healthcare US Ltd. v. Novartis Pharms. Corp.
Case Name: Piramal Healthcare US Ltd. v. Novartis Pharms. Corp., No. 19-12651 (SRC), 2020 U.S. Dist. LEXIS 38849 (D.N.J. Mar. 5, 2020) (Chesler, J.) Drug Product and Patent(s)-in-Suit: Jadenu®...
View ArticleBoehringer Ingelheim Pharms., Inc. v. Mylan Pharms., Inc.
Case Name: Boehringer Ingelheim Pharms., Inc. v. Mylan Pharms., Inc., No. 2019-1172, 2020 U.S. App. LEXIS 8393 (Fed. Cir. Mar. 16, 2020) (Circuit Judges Dyk, Moore, and Hughes presiding; Opinion by...
View ArticleGalderma Labs., L.P. v. Amneal Pharms. LLC
Case Name: Galderma Labs., L.P. v. Amneal Pharms. LLC, No. 2019-1021, 2020 U.S. App. LEXIS 9341 (Fed. Cir. Mar. 25, 2020) (Circuit Judges Lourie, Moore, and Stoll presiding; Opinion by Moore, J.)...
View ArticleAmarin Pharma, Inc. v. Hikma Pharms USA Inc.
Case Name: Amarin Pharma, Inc. v. Hikma Pharms USA Inc., No. 16-cv-02525, 2020 WL 1517568 (D. Nev. March 30, 2020) (Du, J.) Drug Product and Patent(s)-in-Suit: Vascepa® (icosapent ethyl); U.S. Patents...
View ArticleBelcher Pharms., LLC v. Hospira, Inc.
Case Name: Belcher Pharms., LLC v. Hospira, Inc., No. 17-775-LPS, 2020 WL 1650535 (D. Del. Mar. 31, 2020) (Stark, J.)Drug Product and Patent(s)-in-Suit: epinephrine injection; U.S. Patent No. 9,283,197...
View ArticleNew ANDA Cases
table.tableizer-table { border: 1px solid #666; font-size: 12px; } .tableizer-table td { padding: 4px; margin: 3px; border: 1px solid #666; } .tableizer-table th { background-color: #CCC; color: #FFF;...
View ArticleGeneric Launches
table.tableizer-table { border: 1px solid #666; font-size: 12px; } .tableizer-table td { padding: 4px; margin: 3px; border: 1px solid #666; } .tableizer-table th { background-color: #CCC; color: #FFF;...
View ArticleANDA Litigation Settlements
table.tableizer-table { border: 1px solid #666; font-size: 12px; } .tableizer-table td { padding: 4px; margin: 3px; border: 1px solid #666; } .tableizer-table th { background-color: #CCC; color: #FFF;...
View ArticleANDA Approvals
table.tableizer-table { border: 1px solid #666; font-size: 12px; } .tableizer-table td { padding: 4px; margin: 3px; border: 1px solid #666; } .tableizer-table th { background-color: #CCC; color: #FFF;...
View ArticleVol. 14, No. 2
This issue of the Justice Report includes the following:Landlords’ Liability by Elizabeth ForsThe Lowdown on HITECH—The Access Your Clients Still Have to Their Medical Records by Scott...
View ArticleThree Myths the Pandemic Has Debunked: What They Can Teach Law Firms about...
With apologies to Jane Austen, it is a truth universally acknowledged that the legal field is in want of diversity. Change is glacial in the practice of law, a risk-averse sector where seniority and...
View ArticleMentoring Diverse Attorneys During the Pandemic
The value of mentoring in the legal profession cannot be overstated. From a diversity and inclusion perspective, it is critical. But with remote working, diverse attorneys face new challenges that may...
View ArticleInterview with Lauren Bernstein, Director at Curiam Capital LLC
One of the more noteworthy developments over the past few years in the litigation arena has been the rise of litigation funding. A newer name in the industry is Curiam Capital LLC, launched in 2018 by...
View ArticleVol 3. No. 1
EDITORS’ NOTEWe finalized the contents of this edition before the recent tragedies and ensuing protests. Although we have not had time to address the subject with due justice in this edition, we stand...
View ArticleThe Cure: Social Media Influencers and Healthcare
Social media influencers have become the latest source of health information for many. This is especially true right now, amidst the ongoing and rapidly evolving COVID-19 pandemic. More and more...
View ArticleInterview with Stacey Slaughter, Partner at Robins Kaplan LLP
One of our attorneys sits down with Stacey Slaughter, a partner at Robins Kaplan. Ms. Slaughter shares with us insight into her career as a class action litigator and the noteworthy case against Fiat...
View ArticleWhat's a Fiduciary To Do? Considerations for Periods of Uncertainty
In the face of complex disruptions of the sort we have recently experienced, new challenges emerge and old challenges are exacerbated. For those who have undertaken fiduciary obligations to others,...
View Article